Table 1.
Demographic and clinical characteristics of the participants
| HZ patients | PHN patients | Healthy controls | ||
|---|---|---|---|---|
|
| ||||
| Age (years, M ± IQR) | 57.00±12.50 | 65.50±11.25 | 54.00±9.75 | |
| Gender (male:female) | 13/20 | 9/13 | 9/19 | |
| Skin lesions (L:R) | 16/17 | 13/9 | – | |
| Subregions | Head and neck (L:R) | 5/4 | 0/2 | – |
| Upper body (L:R) | 9/4 | 8/5 | – | |
| Lower body (L:R) | 2/9 | 5/2 | – | |
| Pain duration (M ± IQR) | 9.00±11.50 (days) | 2.00±2.25 (months) | – | |
| Shingle duration (M ± IQR) | 8.00±10.50 (days) | 11.50±9.50 (days) | – | |
| VAS score (M ± IQR) | 6.00±2.00 | 6.50±1.00 | – | |
Abbreviations: HZ, herpes zoster; L, left; M, median; PHN, postherpetic neuralgia; R, right; VAS, visual analog scale.